Page results
-
Mike Ryan, aged 67 from Finchley, was diagnosed with oesophageal cancer in August 2017 after noticing pressure in the back of his throat and regurgitation of thick saliva when he ate. He initially…
-
Term: 01/09/2024 – 31/08/2027 Passionate about improving the quality of people’s lives, I feel privileged to be elected a Patient Governor of UCLH Trust when the importance and…
-
Rheumatic conditions include a variety of conditions that can affect your muscles or joints. The most common conditions that we treat in rheumatology are: Juvenile Idiopathic arthritis and…
-
Deborah first started experiencing difficulties swallowing (dysphagia) and a burning sensation in her throat while swallowing food. At first she ignored the problem, but when the difficulties…
-
Jo Moss has been appointed as director of strategy. Jo is currently chief strategy and transformation officer for North East London Integrated Care Board. Before this she was director of…
-
Radiotherapy delivered on a linear accelerator (sometimes termed linac) is a form of ‘external beam' radiotherapy delivered using high energy X-Rays (photons). The department is equipped…
-
Professor Charles Swanton is one of three innovative cancer investigators to be awarded the prestigious Paul Marks Prize for Cancer Research by the Memorial Sloan Kettering Cancer Center (MSK).
-
Chyrel Brown became a non-executive director at UCLH in May 2022 and was appointed as vice-chair in January 2025.
-
Liz O’Hara was appointed as joint chief people officer across UCLH and Whittington Health in March 2024, having held the role of director of workforce at UCLH since March 2020.
-
The trial results are good news for non-small cell lung cancer patients who are not eligible for standard of care platinum-based chemotherapy.
File results
-
FOI/2022/0730 - Outpatient unit day procedures for haematology patients
-
FOI/2022/0748 - Services closed at Trust due to staffing issues
-
FOI/2022/0751 - Pharmacy solution to remotely monitor fridge temperature
-
FOI/2022/0754 - Respiratory devices
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0769 - Non-disclosure agreement to resolve sexual harassment cases
-
FOI/2022/0778 - Phone calls to 09020 44 24 11 from NHS Trust
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0789 - Agencies (including off framework) used to supply locum agency doctors
-
FOI/2022/0795 - Mobile software (communications, chat, photo) used by the Trust